Genital lichen sclerosus after nivolumab

Dermatol Online J. 2020 Nov 15;26(11):13030/qt6qv5v1df.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents, Immunological / adverse effects
  • Female
  • Humans
  • Immune Checkpoint Inhibitors / adverse effects*
  • Melanoma / drug therapy
  • Middle Aged
  • Nivolumab / adverse effects*
  • Vulvar Lichen Sclerosus / chemically induced*

Substances

  • Antineoplastic Agents, Immunological
  • Immune Checkpoint Inhibitors
  • Nivolumab